Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 4 Prostatic Neoplasms 3 Neoplasms 3 Breast Neoplasms 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Pinealoma 1 Parotid Neoplasms 1 Oligodendroglioma 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Multiple Sclerosis 1 Meningioma 1 Meningeal Neoplasms 1 Medulloblastoma 1 Lymphoma 1 Liver Neoplasms 1 Hypoxia 1 Gynecologic Cancer 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Digestive System Diseases 1 Colorectal Neoplasms 1 Choroid Plexus Neoplasms 1 Astrocytoma 1

Interventions

Standard of Care 2 pembrolizumab 1 gadobutrol 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Limonene 1 Erlotinib Hydrochloride 1 Docetaxel 1 Citric Acid 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Parotid Neoplasms × gadobutrol × Clear all

NCT02294838 2016-11-28

SPIT

British Columbia Cancer Agency

Phase NA Unknown

Parotid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡